Felodipine Tablet, Film Coated
Product Images NDC 63629-2017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 63629-2017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (1 Formula)

Image Description (1 Formula)
FDA Label Image

Label (Lbl636292017)

Label (Lbl636292017)
Felodipine is a component of NILD's extended-release tablets. Each tablet contains 2.5 mg of felodipine, USP. These tablets must be kept out of the reach of children and stored between 20°C and 25°C in a tightly sealed, light-resistant container. Protection from direct light is also necessary. This medication is available in a bottle containing 500 tablets and is only available by prescription.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
The text describes mean reductions in blood pressure for different doses of medication over different study periods. The measurements include systolic and diastolic blood pressure, trough and peak response ratios. The study periods are 8 and 4 weeks. It also notes that there were different numbers of patients available for peak and trough measurements.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
This text presents a table with the percentage of patients experiencing adverse events in controlled trials of Felodipine extended-release tablets as monotherapy regardless of causality. The table shows the adverse events related to different doses of Felodipine and a placebo. The experience of the patient in titration studies may have been exposed to more than one dose level of Felodipine-extended release tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.